Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER2 | P43116 | 6/20 | 0.35 |
| ▸ | PTGIR | P43119 | 5/20 | 0.35 |
| ▸ | PTGER3 | P43115 | 4/20 | 0.35 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.35 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 6/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.34 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.34 |
| ▸ | RARB | P10826 | 1/20 | 0.34 |
| ▸ | RARG | P13631 | 1/20 | 0.34 |
| ▸ | DRD1 | P21728 | 1/20 | 0.34 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20815491 | 0.91 | PTGIR (0.43) | PTGER2PTGIRPTGER3PTGER1PTGDR | |
| SCHEMBL20815490 | 0.91 | PTGIR (0.43) | PTGER2PTGIRPTGER3PTGER1PTGDR | |
| SCHEMBL20815486 | 0.80 | PTGIR (0.46) | PTGER2PTGIRPTGER3PTGER1PTGDR | |
| SCHEMBL20815484 | 0.80 | PTGIR (0.46) | PTGER2PTGIRPTGER3PTGER1PTGDR | |
| SCHEMBL20815492 | 0.78 | PTGIR (0.59) | PTGER2PTGIRPTGER3PTGER1PTGDR | |
| SCHEMBL20815493 | 0.78 | PTGIR (0.59) | PTGER2PTGIRPTGER3PTGER1PTGDR | |
| SCHEMBL11457176 | 0.76 | PTGER4 (0.52) | PTGER2PTGIRPTGER3PTGER1PTGDR | |
| SCHEMBL11457175 | 0.76 | PTGER4 (0.52) | PTGER2PTGIRPTGER3PTGER1PTGDR | |
| SCHEMBL22263540 | 0.75 | PDE4D (0.37) | PTGER2PTGIRPTGER3PTGER1PTGDR | |
| SCHEMBL22263537 | 0.75 | PDE4D (0.37) | PTGER2PTGIRPTGER3PTGER1PTGDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10494338-B2 | Prostaglandin derivative | AGC Inc. (JP) | 2019-12-03 | — | — | US | disclosed |
| US-20190135743-A1 | NOVEL PROSTAGLANDIN DERIVATIVE | AGC Inc. (JP) | 2019-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10494338-B2 | Prostaglandin derivative | PTGIR, PTGIS, PTGS1 | PTGER2 10/4885PTGIR 1/4885PTGER3 14/4885 |
| US-20190135743-A1 | NOVEL PROSTAGLANDIN DERIVATIVE | PTGIR, PTGIS, PTGER1 | PTGER2 9/4885PTGIR 1/4885PTGER3 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.